Members |
targetComponentId |
Vessel resection and replacement NOS |
Vessel resection and replacement (procedure) |
Vessel shunt/by-pass NOS |
Vessel shunt/by-pass |
Vessel shunt/by-pass NOS |
Vessel shunt/by-pass |
Vessel surgical occlusion NOS |
Surgical occlusion of blood vessel |
Vessel surgical occlusion NOS |
Surgical occlusion of blood vessel |
Vestibular neuronitis |
Epidemic vertigo |
Veterinary nursing AND/OR grooming procedure |
Nursing procedure |
Vibration NOS |
Vibration - treatment |
Vibration NOS |
Vibration - treatment |
Vibration of cervix |
Uterine cervix manipulation |
Vibration af cervix |
Uterine cervix manipulation |
Vibrio anguillarium |
Listonella anguillarum (organism) |
Vibrio carchariae |
Vibrio harveyi |
Vibrio costicola |
Salinivibrio costicola |
Vibrio damsela |
Photobacterium damselae (organism) |
Vibrio fischeri |
Aliivibrio fischeri |
Vibrio hollisae |
Grimontia hollisae (organism) |
Vibrio marinus |
Moritella marina (organism) |
Vibrio trachuri |
Vibrio harveyi |
Vibrionaceae ichthyoenteri |
Vibrio ichthyoenteri (organism) |
Gør andre til ofre |
Abusive behavior towards people (finding) |
villonodulær synovit |
Diffuse tenosynovial giant cell tumor |
Villonodulær synovit, ikke nærmere specificeret |
Diffuse tenosynovial giant cell tumor |
villonodulær synovit med multiple lokalisationer |
Diffuse tenosynovial giant cell tumor |
Villonodulær synovit, med anden specificeret lokalisation |
Diffuse tenosynovial giant cell tumor |
Villonodulær synovit uden specificeret lokalisation |
Diffuse tenosynovial giant cell tumor |
Villous adenoma |
Villous adenoma |
Vinblastine sulfate 30mg/30mL conventional release solution for injection |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
vinblastinsulfat 30 mg/30 ml infusionsvæske |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
Vinblastine sulfate 50mg/50mL conventional release solution for infusion |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
vinblastinsulfat 50 mg/50 ml infusionsvæske |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
Vinca alkaloid |
Vinca alkaloid |
vincristin 1 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Vincristine only product in parenteral dose form |
Vincristine 1mg powder for injection solution vial |
Vincristine only product in parenteral dose form |
vincristin 2 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Vincristine only product in parenteral dose form |
Vincristine 2mg powder for injection solution vial |
Vincristine only product in parenteral dose form |
vincristin 5 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Vincristine only product in parenteral dose form |
Vincristine 5mg powder for injection solution vial |
Vincristine only product in parenteral dose form |
Vincristine sulfate 10mg/50mL conventional release solution for infusion |
Vincristine only product in parenteral dose form |
vincristinsulfat 10 mg/50 ml infusionsvæske |
Vincristine only product in parenteral dose form |
Vincristine sulfate 5mg/50mL conventional release solution for infusion |
Vincristine only product in parenteral dose form |
vincristinsulfat 5 mg/50 ml infusionsvæske |
Vincristine only product in parenteral dose form |
vinorelbin 10 mg/1 ml infusionsvæske, opløsning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
vinorelbin 50 mg/5 ml infusionsvæske, opløsning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Vinorelbine tartrate 10mg/mL injection solution 1mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Vinorelbine tartrate 10mg/mL injection solution 5mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Vinorelbine tartrate 10mg/mL solution |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Viper type C oncovirus |
Viper retrovirus (organism) |
Vipera |
Subfamily Viperinae (organism) |
Vipera persica |
Pseudocerastes persicus |
Vipoma of uncertain behavior |
Vipoma, malignant |
Viral gastroenteritis due to other viral agents |
Viral gastroenteritis |
Viral hepatitis, non-A, non-B |
Viral hepatitis C |
viral infektion specificeret iht. lokalisation |
Viral disease |
Viral screening NOS |
Viral screening |
Virusscreening, ikke nærmere specificeret |
Viral screening |
Visceral epilepsi |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
viskositetsmodifikator |
Viscosity modifier (substance) |
Visible light therapy NOS |
Visible light therapy |
Visible light therapy NOS |
Visible light therapy |
Visual defect - remedial therapy NOS |
Visual defect-remedial therapy |
Visual defect - remedial therapy NOS |
Visual defect-remedial therapy |
Visual symptom NOS |
Visual symptoms (finding) |
Visual symptom NOS |
Visual symptoms (finding) |
Visual testing NOS |
Visual testing |
Visual testing NOS |
Visual testing |
Visually threatening diabetic retinopathy |
Visually threatening diabetic retinopathy |
Vitamin A deficiency with other ocular manifestations |
Vitamin A deficiency with ocular manifestation |
allergi over for præparat indeholdende B12-vitamin |
Allergy to vitamin B12 and/or vitamin B12 derivative (finding) |
Vitamin B>12< deficiency neuropathy |
Subacute combined degeneration of spinal cord |
Vitamin D3-metabolit |
Vitamin D analogue |
Vitamin P preparation |
Bioflavonoid (substance) |
præparat indeholdende vitamin |
Vitamin supplement (substance) |
Vitropression |
Diascopy procedure |
Vocal |
Vocal resonance |
Vocational trainer NOS |
Vocational trainer |
Vocational trainer NOS |
Vocational trainer |
Vocational training NOS |
Vocational training |
Vocational training NOS |
Vocational training |
Stemmeforstyrrelse forårsaget af transseksualitet |
Speech and language disorder |
undersøgelse af blæretryk under miktion |
Urinary pressure and flow study |
Vandladnings-uretrocystografi |
Fluoroscopic micturating cystourethrography (procedure) |
Volatile inhalant dependence with current use |
Volatile inhalant dependence |
Volumenkontrolleret ventilation |
Continuous mandatory ventilation (regime/therapy) |
frivillig kropspiercing |
Body piercing (finding) |
frivillig tatovering af kroppen |
Tattoo of skin |
Vomit examination NOS |
Vomit examination |
Vomit examination NOS |
Vomit examination |
Vomit examination general NOS |
Vomit examination |
Vomit occult blood NOS |
Occult blood detected in vomitus |
Vomit occult blood NOS |
Vomit occult blood |
opkastets lugt, ikke nærmere specificeret |
Odor of vomit |
Vomit odour NOS |
Vomit odor - finding |
Vomit pH NOS |
Finding of vomit pH (finding) |
Vomit pH NOS |
Measurement of vomit pH |
Vomit toxicology NOS |
Vomit toxicology |
Vomit toxicology NOS |
Vomit toxicology |
Vomit: appearance NOS |
Vomit appearance - finding |
opkastets udseende, ikke nærmere specificeret |
Vomit appearance |
opkastning |
Vomiting (disorder) |
Vomiting NOS |
Vomiting (disorder) |